Bee Venom-Loaded Niosomes as Innovative Platforms for Cancer Treatment: Development and Therapeutical Efficacy and Safety Evaluation
Pharmaceuticals · 29.04.2024 · 17 (5) · 572
DOI: 10.3390/ph17050572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 29.04.2024. Verfasst von Maria Beatriz Pinto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Azinhaga de Santa Comba, 3000-548 C…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research and Development Project, national funds FCT/MCTES (PIDDAC), CIMO funds, SusTEC funds.
Abstract (Originalsprache)
Despite past efforts towards therapeutical innovation, cancer remains a highly incident and lethal disease, with current treatments lacking efficiency and leading to severe side effects. Hence, it is imperative to develop new, more efficient, and safer therapies. Bee venom has proven to have multiple and synergistic bioactivities, including antitumor effects. Nevertheless, some toxic effects have been associated with its administration. To tackle these issues, in this work, bee venom-loaded niosomes were developed, for cancer treatment. The vesicles had a small (150 nm) and homogeneous (polydispersity index of 0.162) particle size, and revealed good therapeutic efficacy in in vitro gastric, colorectal, breast, lung, and cervical cancer models (inhibitory concentrations between 12.37 ng/mL and 14.72 ng/mL). Additionally, they also revealed substantial anti-inflammatory activity (inhibitory concentration of 28.98 ng/mL), effects complementary to direct antitumor activity. Niosome safety was also assessed, both in vitro (skin, liver, and kidney cells) and ex vivo (hen’s egg chorioallantoic membrane), and results showed that compound encapsulation increased its safety. Hence, small, and homogeneous bee venom-loaded niosomes were successfully developed, with substantial anticancer and anti-inflammatory effects, making them potentially promising primary or adjuvant cancer therapies. Future research should focus on evaluating the potential of the developed platform in in vivo models.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.
- REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, 3000-548 Coimbra, Portugal.
- Health Sciences Research Centre (CICS-UBI), University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
- Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
- Laboratório Associado para a Sustentabilidade e Tecnologia em Regiões de Montanha (SusTEC), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China.
ORCID-Profile: Maria Beatriz Pinto, Patrícia C Pires, Ricardo C Calhelha, Ana Rita Silva, Miguel Vilas-Boas, Soraia I Falcão, Pooyan Makvandi, Ana Cláudia Paiva-Santos
Förderung
- Research and Development Project
- national funds FCT/MCTES (PIDDAC), CIMO funds
- SusTEC funds
- Fundação para a Ciência e a Tecnologia I.P. (FCT, Portugal)
Zitieren
APA
Pinto, M. B., Pires, P. C., Calhelha, R. C., Silva, A. R., Sousa, M. J., Vilas-Boas, M., Falcão, S. I., Veiga, F., Makvandi, P., & Paiva-Santos, A. C. (2024). Bee Venom-Loaded Niosomes as Innovative Platforms for Cancer Treatment: Development and Therapeutical Efficacy and Safety Evaluation. Pharmaceuticals, 17(5), 572. https://doi.org/10.3390/ph17050572
Vancouver
Pinto MB, Pires PC, Calhelha RC, Silva AR, Sousa MJ, Vilas-Boas M, et al. Bee Venom-Loaded Niosomes as Innovative Platforms for Cancer Treatment: Development and Therapeutical Efficacy and Safety Evaluation. Pharmaceuticals. 2024;17(5):572. doi:10.3390/ph17050572
BibTeX
@article{Pinto2024,
author = {Pinto, Maria Beatriz and Pires, Patrícia C and Calhelha, Ricardo C and Silva, Ana Rita and Sousa, Maria João and Vilas-Boas, Miguel and Falcão, Soraia I and Veiga, Francisco and Makvandi, Pooyan and Paiva-Santos, Ana Cláudia},
title = {Bee Venom-Loaded Niosomes as Innovative Platforms for Cancer Treatment: Development and Therapeutical Efficacy and Safety Evaluation},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {5},
pages = {572},
doi = {10.3390/ph17050572}
}
EUVIMED